title: Knockdown of caveolin-1 decreases activity of breast cancer resistance protein (BCRP/ABCG2) and increases chemotherapeutic sensitivity.
authors.affiliation: Department of Clinical Pharmacology and Pharmacoepidemiology, University of Heidelberg, Im Neuenheimer Feld 410, 69120 Heidelberg, Germany.
authors.forename: Melanie
authors.initials: M
authors.lastname: Herzog
authors.forename: Caroline Henrike
authors.initials: CH
authors.lastname: Storch
authors.forename: Philipp
authors.initials: P
authors.lastname: Gut
authors.forename: Dimitry
authors.initials: D
authors.lastname: Kotlyar
authors.forename: Joachim
authors.initials: J
authors.lastname: Füllekrug
authors.forename: Robert
authors.initials: R
authors.lastname: Ehehalt
authors.forename: Walter Emil
authors.initials: WE
authors.lastname: Haefeli
authors.forename: Johanna
authors.initials: J
authors.lastname: Weiss